The city of Madison, Wisconsin, currently has 1 active clinical trials seeking participants for Parkinson's Disease research studies.
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
Recruiting
The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered to the putamen in subjects with moderate Parkinson's Disease.
Gender:
ALL
Ages:
Between 45 years and 75 years
Trial Updated:
06/23/2025
Locations: University of Wisconsin (Neurology), Madison, Wisconsin
Conditions: Parkinson Disease